Arteriocyte Inc

Overview Synapse Biomedical Inc ( SBI ) was founded in September 2002 to commercialize the NeuRx Diaphragm Pacing System ( DPS ) that has been developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland. The innovative research performed at these institutions has led to significant advances in the state of the art of electrical stimulation for the treatment of chronic respiratory insufficiency. This innovation allows the technology to meet clinical needs, beyond the ability of the currently available systems, in spinal cord injuries, in the diaphragm conditioning in muscular dystrophies ( such as ALS ) and in respiratory short-term intensive care setting.

Molecular Theranostics, LLC is an early stage biotechnology company based in Cleveland, OH, specializing in novel imaging technologies. Their cutting-edge research and development efforts aim to address the unmet clinical needs for early detection, risk-stratification, and active surveillance of aggressive cancers, as well as non-invasive assessment of the efficacy of cancer therapies. With a focus on innovation, Molecular Theranostics is dedicated to advancing the field of theranostics, offering promising solutions for the diagnosis and treatment of cancer. Through their state-of-the-art pipelines, they strive to provide valuable tools that can revolutionize cancer care and improve patient outcomes.Generated from the website

Centerline Biomedical, Inc is a Cleveland-based company that specializes in providing innovative navigation technology for endovascular procedures. Their FDA cleared Intra-Operative Positioning System (IOPS) offers real-time navigation and high-quality 3D image guidance, reducing radiation exposure and improving accuracy. With a mission to create a safer and more accessible healthcare environment, Centerline Biomedical aims to mitigate the risks associated with radiation exposure and enhance patient outcomes. By replacing the current gold standard of X-Ray Fluoroscopy, which relies on harmful radiation and low-quality 2D image guidance, Centerline Biomedical's IOPS offers interactive navigation, portable systems, and decreased radiation exposure. The company's technology addresses the growing concerns of radiation-related health issues among healthcare professionals, such as cataracts, brain tumors, and orthopedic problems. With collaborations and endorsements from renowned medical professionals, Centerline Biomedical is poised to revolutionize the field of endovascular therapy.Generated from the website